miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

(2017) J. Alfred Witjes et al.   EUROPEAN UROLOGY

MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5

(2017) T.K. Li et al.   GENETICS AND MOLECULAR RESEARCH

Overexpression of miR-214 promotes the progression of human osteosarcoma by regulating the Wnt/β-catenin signaling pathway

(2017) Xun-Bing Zhu et al.   Molecular Medicine Reports

Overexpression of SLC34A2 is an independent prognostic indicator in bladder cancer and its depletion suppresses tumor growth via decreasing c-Myc expression and transcriptional activity

(2017) Wen Ye et al.   Cell Death & Disease

MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2

(2017) Alip Ghosh et al.   Cell Death & Disease

miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade

(2016) Jiaxuan Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma

(2016) Khalda Said Amr et al.   GENE

The translational potential of microRNAs as biofluid markers of urological tumours

(2016) Annika Fendler et al.   Nature Reviews Urology

Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma

(2016) Julia Liep et al.   PLoS One

Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment

(2015) Margaritis Avgeris et al.   CARCINOGENESIS

STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

(2015) P. M. Bossuyt et al.   CLINICAL CHEMISTRY

Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature

(2015) Luis A. Kluth et al.   EUROPEAN UROLOGY

Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence

(2015) Angeline S. Andrew et al.   INTERNATIONAL JOURNAL OF CANCER

Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?

(2015) Maria Schubert et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1

(2015) P Phatak et al.   ONCOGENE

MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival

(2015) Zheng Xu et al.   TUMOR BIOLOGY

MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer

(2015) Jinfeng Wang et al.   PLoS One

MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy

(2015) Andreas-Claudius Hoffmann et al.   NEOPLASIA

miR-199a-3p Inhibits Aurora Kinase A and Attenuates Prostate Cancer Growth

(2014) Yi Qu et al.   AMERICAN JOURNAL OF PATHOLOGY

MiR-199a-3p promotes gastric cancer progression by targeting ZHX1

(2014) Zhenqiang Wang et al.   FEBS LETTERS

Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer

(2014) Anirban P. Mitra et al.   JNCI-Journal of the National Cancer Institute

Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer

(2014) Xiao-Lin Wang et al.   TUMOR BIOLOGY

A miR-199a/miR-214 Self-Regulatory Network via PSMD10, TP53 and DNMT1 in Testicular Germ Cell Tumor

(2014) Bi-Feng Chen et al.   Scientific Reports

Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer

(2013) S. Wang et al.   Clinical & Translational Oncology

Biomarkers in bladder cancer: Translational and clinical implications

(2013) Liang Cheng et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

(2013) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

(2013) J. Alfred Witjes et al.   EUROPEAN UROLOGY

miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome

(2013) Nadine Ratert et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers

(2013) Daiwei Wan et al.   MEDICAL ONCOLOGY

The evolving understanding of microRNA in bladder cancer

(2013) Elizabeth A. Guancial et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

miR-143, miR-222, and miR-452 Are Useful as Tumor Stratification and Noninvasive Diagnostic Biomarkers for Bladder Cancer

(2012) Patricia Puerta-Gil et al.   AMERICAN JOURNAL OF PATHOLOGY

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

(2012) Iver Nordentoft et al.   BMC Medical Genomics

microRNA expression profile in a large series of bladder tumors: Identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer

(2012) Géraldine Pignot et al.   INTERNATIONAL JOURNAL OF CANCER

DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways

(2012) Ioannis S. Vlachos et al.   NUCLEIC ACIDS RESEARCH

Reference miRNAs for miRNAome Analysis of Urothelial Carcinomas

(2012) Nadine Ratert et al.   PLoS One

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

(2012) Douglas G. Altman et al.   PLOS MEDICINE

Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β

(2011) Masaaki Tsukigi et al.   CANCER LETTERS

Comparative mRNA and microRNA Expression Profiling of Three Genitourinary Cancers Reveals Common Hallmarks and Cancer-Specific Molecular Events

(2011) Xianxin Li et al.   PLoS One

Genomic Profiling of MicroRNAs in Bladder Cancer: miR-129 Is Associated with Poor Outcome and Promotes Cell Death In vitro

(2009) L. Dyrskjot et al.   CANCER RESEARCH

Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer

(2009) J. W.F. Catto et al.   CANCER RESEARCH

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY

Identification of novel microRNA targets based on microRNA signatures in bladder cancer

(2009) Takahiro Ichimi et al.   INTERNATIONAL JOURNAL OF CANCER

The search for new cardiovascular biomarkers

(2008) Robert E. Gerszten et al.   NATURE

A microRNA expression ratio defining the invasive phenotype in bladder tumors

(2008) Lori A. Neely et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS